0

524606

BERLDRG

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BERYL DRUGS LTD. Share Price Today

Investment Returns

Over 1 Month 12.29% Over 3 Months 12.67% Over 6 Months 5.54% Over 1 Year 15.21%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BERYL DRUGS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 11.70
  • P/E Ratio (TTM) 27.40
  • Beta 0.80
  • Book Value / share 19.44
  • Return on equity 6.30%
  • EPS (TTM) 0.84
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.56
info icon alternate text

BERYL DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 5.13
Operating Expense 4.60
Net Profit 0.56
Net Profit Margin (%) 10.91
Earnings Per Share (EPS) 1.11
EBITDA 1.33
Effective Tax Rate (%) 34.48
Particulars DEC 2025 (Values in Cr)
Revenue 3.78
Operating Expense 4.46
Net Profit -0.17
Net Profit Margin (%) -4.49
Earnings Per Share (EPS) -0.33
EBITDA -0.20
Effective Tax Rate (%) 72.13
Particulars SEP 2025 (Values in Cr)
Revenue 5.12
Operating Expense 4.90
Net Profit 0.01
Net Profit Margin (%) 0.19
Earnings Per Share (EPS) 0.02
EBITDA 0.73
Effective Tax Rate (%) 96.15
Particulars JUN 2025 (Values in Cr)
Revenue 4.79
Operating Expense 4.77
Net Profit 0.02
Net Profit Margin (%) 0.41
Earnings Per Share (EPS) 0.04
EBITDA 0.55
Effective Tax Rate (%) 71.42
Particulars MAR 2025 (Values in Cr)
Revenue 3.97
Operating Expense 5.12
Net Profit 0.15
Net Profit Margin (%) 3.77
Earnings Per Share (EPS) 0.30
EBITDA 0.50
Effective Tax Rate (%) -50.00
Particulars MAR 2026 (Values in Cr)
Revenue 18.82
Operating Expense 18.72
Net Profit 0.42
Net Profit Margin (%) 2.23
Earnings Per Share (EPS) 0.84
EBITDA 2.42
Effective Tax Rate (%) 27.11
Particulars MAR 2025 (Values in Cr)
Revenue 21.15
Operating Expense 21.69
Net Profit 0.58
Net Profit Margin (%) 2.74
Earnings Per Share (EPS) 1.14
EBITDA 2.65
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 26.73
Operating Expense 26.11
Net Profit 0.77
Net Profit Margin (%) 2.88
Earnings Per Share (EPS) 1.52
EBITDA 2.67
Effective Tax Rate (%) 23.76
Particulars MAR 2023 (Values in Cr)
Revenue 26.89
Operating Expense 26.18
Net Profit 0.77
Net Profit Margin (%) 2.86
Earnings Per Share (EPS) 1.52
EBITDA 2.21
Effective Tax Rate (%) 22.44
Particulars MAR 2022 (Values in Cr)
Revenue 14.60
Operating Expense 15.71
Net Profit -0.66
Net Profit Margin (%) -4.52
Earnings Per Share (EPS) -1.30
EBITDA 0.58
Effective Tax Rate (%) 30.52
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.66
ROE % 6.30
ROCE % 9.93
Total Debt to Total Equity 0.50
EBITDA Margin 12.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.52
ROE % 9.07
ROCE % 10.80
Total Debt to Total Equity 0.57
EBITDA Margin 10.03
Particulars MAR 2023 (Values in Cr)
Book Value / Share 15.84
ROE % 10.03
ROCE % 11.25
Total Debt to Total Equity 0.64
EBITDA Margin 8.44
Particulars MAR 2022 (Values in Cr)
Book Value / Share 14.32
ROE % -8.67
ROCE % -3.72
Total Debt to Total Equity 0.68
EBITDA Margin 4.11
Particulars MAR 2021 (Values in Cr)
Book Value / Share 15.57
ROE % -1.29
ROCE % 2.79
Total Debt to Total Equity 0.67
EBITDA Margin 11.64
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.81
Total Assets 15.96
Total Liabilities 15.96
Total Equity 9.50
Share Outstanding 0
Price to Book Ratio 1.13
Return on Assets (%) 3.62
Return on Capital (%) 4.26
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 17.48
Total Liabilities 17.48
Total Equity 8.92
Share Outstanding 0
Price to Book Ratio 1.67
Return on Assets (%) 4.39
Return on Capital (%) 5.48
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.57
Total Assets 17.51
Total Liabilities 17.51
Total Equity 8.06
Share Outstanding 0
Price to Book Ratio 0.77
Return on Assets (%) 4.37
Return on Capital (%) 6.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.27
Total Assets 17.82
Total Liabilities 17.82
Total Equity 7.29
Share Outstanding 0
Price to Book Ratio 0.73
Return on Assets (%) -3.69
Return on Capital (%) -5.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 18.64
Total Liabilities 18.64
Total Equity 7.92
Share Outstanding 0
Price to Book Ratio 0.42
Return on Assets (%) 1.28
Return on Capital (%) 1.84
Particulars MAR 2025 (Values in Cr)
Net Income 0.86
Cash from Operations 2.81
Cash from Investing -0.39
Cash from Financing -1.55
Net change in Cash 0.68
Free Cash Flow 5.00
Particulars MAR 2024 (Values in Cr)
Net Income 1.00
Cash from Operations 1.02
Cash from Investing -1.08
Cash from Financing 0.10
Net change in Cash -0.15
Free Cash Flow 2.37
Particulars MAR 2023 (Values in Cr)
Net Income 0.98
Cash from Operations 2.54
Cash from Investing -1.30
Cash from Financing -1.16
Net change in Cash 0.01
Free Cash Flow 4.10
Particulars MAR 2022 (Values in Cr)
Net Income -0.95
Cash from Operations -0.43
Cash from Investing 0.52
Cash from Financing -0.23
Net change in Cash -0.18
Free Cash Flow -0.02
Particulars MAR 2021 (Values in Cr)
Net Income 0.34
Cash from Operations 0.36
Cash from Investing 0.25
Cash from Financing -0.53
Net change in Cash 0.05
Free Cash Flow 1.41
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LIMITED 338.80 14.94 2.45 997.12 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2120.70 37.34 15.84 35925.94 2088.00 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD 438.10 47.26 4.02 4646.32 118.35 462.70

BERYL DRUGS LTD. shareholding pattern

Holding
72.52%
27.47%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BERYL DRUGS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
23.02 -0.08 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 23.20
  • 26 Days 21.90
  • 10 Days 22.70
  • 50 Days 21.70
  • 12 Days 22.50
  • 100 Days 21.80
  • 20 Days 22.10
  • 200 Days 22.50
23.79 PIVOT
First Support 22.29 First Resistance 24.55 Second Support 21.53 Second Resistance 26.05 Third Support 20.03 Third Resistance 26.81
RSI 57.29 ADX 25.26 MACD 0.61 Williams % R -36.25 Commodity Channel Index (CCI) 83.89
Date 2026-06-12 Week 4174.00 Same Day 41.00 Month 2138.00
1 Year 0.80 3 Year 0.63
Over 1 Month
12.29% down
Over 1 Year
15.21% down
Over 3 Months
12.67% down
Over 3 Years
14.71% down
Over 6 Months
5.54% down
Over 5 Years
23.14% down

BERYL DRUGS LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Beryl Drugs Ltd?

Answer Field

Beryl Drugs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 23.02 as on Jun 12 2026 03:29 PM.

What is the Market Cap of Beryl Drugs Ltd Share?

Answer Field

The market cap of Beryl Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 11.70 as on Jun 12 2026 03:29 PM.

What is the 52 Week High and Low of Beryl Drugs Ltd?

Answer Field

The 52 Week High and Low of Beryl Drugs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 30.00 and ₹ 15.92.

What is 1 year return for Beryl Drugs Ltd?

Answer Field

The 1 year returns on the stock has been 15.21%.

What is the P/E Ratio of Beryl Drugs Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM the price-to-earnings (PE) ratio for Beryl Drugs Ltd share is 27.40.

What is the PB ratio of Beryl Drugs Ltd Share?

Answer Field

As on Jun 12 2026 03:29 PM, the price-to-book (PB) ratio for Beryl Drugs Ltd share is 19.44.

How to Buy Beryl Drugs Ltd Share?

Answer Field

You can trade in Beryl Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Beryl Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Beryl Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Beryl Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|